adminの記事一覧

Effect of linagliptin on oxidative stress markers in patients with type 2 diabetes: a pilot study.

Diabetol Int. 2018PubMed

Urinary Level of Liver-Type Fatty Acid Binding Protein Reflects the Degree of Tubulointerstitial Damage in Polycystic Kidney Disease.

Kidney Blood Press Res. 2018PubMed

Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on cisplatin-induced nephrotoxicity in mice.

Naunyn Schmiedebergs Arch Pharmacol. 2018PubMed

Predicting acute kidney injury using urinary liver-type fatty-acid binding protein and serum N-terminal pro-B-type natriuretic peptide levels in patients treated at medical cardiac intensive care units.

Crit Care. 2018PubMed

健診受診者の5.3％が早期慢性腎臓病　就労世代8万人の健診データを分析

■━━━━━━━━━━━━━━━━━━━━━━━━■腎疾患診断用バイオマーカー L-FABP情報サイト■□■□メールマガジン□■□■No.65／2024年3月配信号［医療者向け］https://fabp.jp/?utm_source=mailmagazine&utm_campaign=240

Urinary liver-type fatty acid-binding protein levels as a potential risk factor for renal dysfunction in male HIV-infected Japanese patients receiving antiretroviral therapy: a pilot study.

Int J STD AIDS. 2018PubMed

Increased urinary liver-type fatty acid-binding protein level predicts worsening renal function in patients with acute heart failure.

J Card Fail. 2018PubMed

Urinary Liver Type Fatty Acid Binding Protein Is Negatively Associated With Estimated Glomerular Filtration Rate in Renal Transplant Recipients With Graft Loss.

Transplant Proc. 2018PubMed

Biomarkers of AKI Progression after Pediatric Cardiac Surgery.

J Am Soc Nephrol. 2018PubMed

Urinary L-FABP level in children with nephrotic syndrome and tubular dysfunction.

Pediatr Int. 2018PubMed